ClearOne surges as Cortigent merger approval clears a key closing hurdle

By: Quiver PriceTracker

Posted: 4 weeks ago / Sept. 28, 2026 2:50 p.m. UTC

CLRO

ClearOne, Inc. (CLRO) is up 43.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely catalyst is investor reaction to merger progress tied to ClearOne’s planned combination with Cortigent, a unit of Vivani Medical. A key filing showed majority stockholders had already approved the issuance of 12.5 million shares needed for the deal, which appears to have revived speculative buying in a very small-cap stock.

Details:

ClearOne disclosed a merger agreement under which Cortigent would become a wholly owned subsidiary, and the combined company is expected to be renamed Cortigent Holdings with a planned Nasdaq symbol of CRGT.

An information statement showed holders of about 61.3% of ClearOne’s voting stock approved the share issuance required for the transaction, satisfying an important governance step.

The filing also outlined a planned financing of roughly $10 million to $15 million as a condition to closing, suggesting the merger process was moving from announcement stage toward execution.

Trading activity had already become unusually heavy around merger-related developments, so the sharp move may also reflect momentum trading and the stock’s limited float amplifying the reaction.

Sources:

SEC, ClearOne Investor Relations, Stock Analysis

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CLRO Hedge Fund Activity

We have seen 2 institutional investors add shares of $CLRO stock to their portfolio, and 5 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DRW SECURITIES, LLC removed 30,064 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $107,027
SHAY CAPITAL LLC removed 10,114 shares (-18.2%) from their portfolio in Q2 2026, for an estimated $33,679
GEODE CAPITAL MANAGEMENT, LLC removed 2,991 shares (-21.6%) from their portfolio in Q2 2026, for an estimated $9,960
TOWER RESEARCH CAPITAL LLC (TRC) added 522 shares (+81.7%) to their portfolio in Q2 2026, for an estimated $1,738
UBS GROUP AG removed 407 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,448
BANK OF AMERICA CORP /DE/ removed 8 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $28
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD added 1 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.